Natural Capsules Limited — Investor Meet, 03-06-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Natural Capsules reported Q4 FY26 consolidated revenue of Rs. 58.45 Cr (+55% QoQ). However, FY26 closed with a net loss of Rs. 24.66 Cr, mainly due to a plant shutdown and API subsidiary pre-commercial costs. Management's primary goal is restoring consolidated profitability in FY27. The new HPMC line is ready, with revenue expected from H2 FY27. Commercial API sales began in Q4 FY26, complemented by a Fermbox partnership utilizing spare fermentation capacity and adding an incremental revenue stream. FY27 revenue is forecast at Rs. 274 Cr, with efforts underway to secure funding for liquidity and target higher-margin regulated markets.